all report title image

PULMONARY SURFACTANT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Pulmonary Surfactant Market, By Type (Synthetic Pulmonary Surfactant, Animal Derived Surfactant), By Drug Type (Poractant alfa, Lucinactant, Calfactant), By Indications (Respiratory Distress Syndrome (RDS), Respiratory Infections, Obstructive lung Diseases, Others (chronic lung disease of prematurity, and surfactant protein-B deficiency)), By Route of Administration (Intratracheal, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 27 Mar, 2026
  • Code: CMI5324
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Indications
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Industry Trend
    • New Product Approvals/Launch
    • Merger and Acquisitions
    • PEST Analysis
  4. Global Pulmonary Surfactant Market, By Type, 2026 – 2033, (USD Million)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Synthetic Pulmonary Surfactant
      •  Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Animal Derived Surfactant
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  5. Global Pulmonary Surfactant Market, By Drug Type, 2026 – 2033, (USD Million)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Poractant alfa
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Lucinactant
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Calfactant
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  6. Global Pulmonary Surfactant Market, By Indications, 2026 – 2033, (USD Million)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Respiratory Distress Syndrome (RDS)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Respiratory Infections
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Obstructive lung Diseases
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Others(chronic lung disease of prematurity, and surfactant protein-B deficiency)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  7. Global Pulmonary Surfactant Market, By Route of Administration, 2026 – 2033, (USD Million)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Intratracheal
      •  Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Injectable
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  8. Global Pulmonary Surfactant Market, By Distribution Channel, 2026 – 2033, (USD Million)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) 
  9. Global Pulmonary Surfactant Market, By Region, 2026 – 2033, (USD Million)

    • Introduction
      • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2021-2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • UK
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indications, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape

    • Heat Map Analysis
    • Company Profile
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Chiesi Farmaceutici
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ONY Biotech Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Lyomark Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aviva Systems Biology Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Windtree Therapeutics, Inc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Tekzima (Noargen)
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Biomatik
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nanjing Norris Pharm Technology
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Reddot Biotech
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  11. Section

    • References
    • Research Methodology
    • About Us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.